BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15803440)

  • 21. Randomization by minimization for unbalanced treatment allocation.
    Han B; Enas NH; McEntegart D
    Stat Med; 2009 Nov; 28(27):3329-46. PubMed ID: 19739238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Knipschild PG
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).
    Tanaka Y; Matsuyama Y; Ohashi Y;
    Stat Med; 2008 May; 27(10):1718-33. PubMed ID: 17922525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample size determination for constrained longitudinal data analysis.
    Lu K; Mehrotra DV; Liu G
    Stat Med; 2009 Feb; 28(4):679-99. PubMed ID: 19051207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint.
    Xie T; Waksman J
    Stat Med; 2003 Sep; 22(18):2835-46. PubMed ID: 12953283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate.
    Timmesfeld N; Schäfer H; Müller HH
    Stat Med; 2007 May; 26(12):2449-64. PubMed ID: 17080491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Power and sample size simulations for Randomized Play-the-Winner rules.
    Guimaraes P; Palesch Y
    Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MSurvPow: a FORTRAN program to calculate the sample size and power for cluster-randomized clinical trials with survival outcomes.
    Gao F; Manatunga AK; Chen S
    Comput Methods Programs Biomed; 2005 Apr; 78(1):61-7. PubMed ID: 15780890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
    Correa JA; Bellavance F
    Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating sample size for a randomized clinical trial of lung cancer screening.
    Obuchowski NA
    Contemp Clin Trials; 2008 Jul; 29(4):466-77. PubMed ID: 18088564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size and statistical power assessing the effect of interventions in the context of mixture distributions with detection limits.
    Chu H; Nie L; Cole SR
    Stat Med; 2006 Aug; 25(15):2647-57. PubMed ID: 16456897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variance identification and efficiency analysis in randomized experiments under the matched-pair design.
    Imai K
    Stat Med; 2008 Oct; 27(24):4857-73. PubMed ID: 18618425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brick tunnel randomization for unequal allocation to two or more treatment groups.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2011 Apr; 30(8):812-24. PubMed ID: 21432876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple hybrid variance estimator for the Kaplan-Meier survival function.
    Borkowf CB
    Stat Med; 2005 Mar; 24(6):827-51. PubMed ID: 15558837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.